Feng-Rong Wang
Overview
Explore the profile of Feng-Rong Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
176
Citations
1786
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao C, Xiao M, Zhang F, Bai L, Hu G, Suo P, et al.
Br J Haematol
. 2025 Feb;
PMID: 39994922
The outcomes are poor for paediatric patients with T-cell acute lymphoblastic leukaemia (T-ALL) who relapse after haematopoietic stem cell transplantation (HSCT). However, studies focusing on paediatric patients with T-ALL following...
2.
Zhou J, Chen Y, Yuan H, Xu Y, Huang X, Gao S, et al.
Bone Marrow Transplant
. 2024 Nov;
60(3):310-318.
PMID: 39587323
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell malignancy and the only curable therapy is allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, allo-HSCT is not appropriate for all...
3.
Li S, Yu C, Xu L, Wang Y, Zhang X, Chen H, et al.
Bone Marrow Transplant
. 2024 Nov;
60(3):277-285.
PMID: 39550501
We aimed to prospectively explore the risk factors for measurable residual disease (MRD) positivity after allogeneic stem cell transplantation (allo-SCT) in AML patients (n = 478). The cumulative incidences (CIs)...
4.
Ma R, Liao Y, Zhang X, Xu L, Wang Y, Mo X, et al.
Bone Marrow Transplant
. 2024 Nov;
60(1):107-109.
PMID: 39506074
No abstract available.
5.
Deng D, Ma X, Wu Z, Zhang X, Xu L, Wang Y, et al.
Blood Sci
. 2024 Sep;
6(4):e00207.
PMID: 39328249
We aimed to identify dynamic changes of lysine (K)-specific methyltransferase 2A partial tandem duplications (-PTD) before and after haploidentical donor hematopoietic stem cell transplantation (HID HSCT) and explore the prognostic...
6.
Feng C, Zhao P, Fu H, Yan C, Wang C, Zhu X, et al.
Cancer Lett
. 2024 Aug;
603:217202.
PMID: 39216549
The incidence of herpes zoster (HZ) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients is significantly higher than that of the general public. Although routine antiviral prophylaxis is recommended, late-onset...
7.
Wu J, He Y, Huang Q, He Y, Zhao P, Chen Q, et al.
Br J Haematol
. 2024 Aug;
205(4):1477-1488.
PMID: 39099079
The objective of this study was to identify independent prognostic factors of viral encephalitis (VE) after allogeneic haematopoietic stem cell transplantation (allo-HSCT) and establish a prognostic model to identify post-transplant...
8.
Jiang X, Zhang X, Xu L, Wang Y, Yan C, Chen H, et al.
Cell Transplant
. 2024 Jun;
33:9636897241257568.
PMID: 38832653
Basiliximab is an important treatment for steroid-refractory acute graft-versus-host disease (SR-aGVHD). We performed this retrospective study to evaluate the efficacy and safety of basiliximab treatment in SR-aGVHD patients following matched...
9.
Wen Q, Guo Z, Zhang X, Xu L, Wang Y, Yan C, et al.
Sci Rep
. 2024 May;
14(1):11778.
PMID: 38782966
We aimed to identify the severity and duration of COVID-19 infection on complications after allo-HSCT. Enrolled 179 hospitalized patients with COVID-19 were categorized into long-term infection (> 18 days, n ...
10.
Cao L, Wen Q, Liu B, Zhao Z, Zhang X, Xu L, et al.
Blood Sci
. 2024 May;
6(3):e00190.
PMID: 38779304
Engraftment syndrome (ES) is one of the most common complications in the early phase after autologous hematopoietic stem cell transplantation (ASCT), and we aimed to evaluate the incidence and risk...